Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

244 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Survival of influenza viruses on environmental surfaces.
Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH Jr. Bean B, et al. J Infect Dis. 1982 Jul;146(1):47-51. doi: 10.1093/infdis/146.1.47. J Infect Dis. 1982. PMID: 6282993
To investigate the transmission of influenza viruses via hands and environmental surfaces, the survival of laboratory-grown influenza A and influenza B viruses on various surfaces was studied. Both influenza A and B viruses survived for 24-48 hr on hard, nonporous s …
To investigate the transmission of influenza viruses via hands and environmental surfaces, the survival of laboratory-grown influenza A and …
Influenza B: hospital activity during a community epidemic.
Bean B, Rhame FS, Hughes RS, Weiler MD, Peterson LR, Gerding DN. Bean B, et al. Diagn Microbiol Infect Dis. 1983 Sep;1(3):177-83. doi: 10.1016/0732-8893(83)90016-0. Diagn Microbiol Infect Dis. 1983. PMID: 6673894
Twenty-five cases of influenza B (18.5% of febrile patients) were identified; no clusters of influenza-like illness occurred. ...Influenza B may be difficult to diagnose clinically in hospitalized patients, but viral throat cultures performed in all suspected cases …
Twenty-five cases of influenza B (18.5% of febrile patients) were identified; no clusters of influenza-like illness occurred. ...Infl …
Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster.
Bean B, Aeppli D. Bean B, et al. J Infect Dis. 1985 Feb;151(2):362-5. doi: 10.1093/infdis/151.2.362. J Infect Dis. 1985. PMID: 3881542 Clinical Trial. No abstract available.
Acyclovir halts progression of herpes zoster in immunocompromised patients.
Balfour HH Jr, Bean B, Laskin OL, Ambinder RF, Meyers JD, Wade JC, Zaia JA, Aeppli D, Kirk LE, Segreti AC, Keeney RE. Balfour HH Jr, et al. Among authors: bean b. N Engl J Med. 1983 Jun 16;308(24):1448-53. doi: 10.1056/NEJM198306163082404. N Engl J Med. 1983. PMID: 6343861 Clinical Trial.
Acyclovir in shingles.
Bean B, Aeppli D, Balfour HH Jr. Bean B, et al. J Antimicrob Chemother. 1983 Sep;12 Suppl B:123-7. doi: 10.1093/jac/12.suppl_b.123. J Antimicrob Chemother. 1983. PMID: 6355047 Review.
Acyclovir therapy for acute herpes zoster.
Bean B, Braun C, Balfour HH Jr. Bean B, et al. Lancet. 1982 Jul 17;2(8290):118-21. doi: 10.1016/s0140-6736(82)91090-x. Lancet. 1982. PMID: 6123837 Clinical Trial.
Therapy of herpes zoster with oral acyclovir.
Huff JC, Bean B, Balfour HH Jr, Laskin OL, Connor JD, Corey L, Bryson YJ, McGuirt P. Huff JC, et al. Among authors: bean b. Am J Med. 1988 Aug 29;85(2A):84-9. Am J Med. 1988. PMID: 3044099 Clinical Trial.
Response of immunocompromised patients with acute herpes zoster to intravenous acyclovir.
McMonigal KA, Balfour HH Jr, Bean B. McMonigal KA, et al. Among authors: bean b. Minn Med. 1987 Jun;70(6):333-5. Minn Med. 1987. PMID: 3037291 No abstract available.
Acyclovir in the treatment of herpesvirus infections.
Bean B. Bean B. Postgrad Med. 1983 Mar;73(3):297-303. doi: 10.1080/00325481.1983.11697814. Postgrad Med. 1983. PMID: 6681899 No abstract available.
Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy.
Bean B, Fletcher C, Englund J, Lehrman SN, Ellis MN. Bean B, et al. Diagn Microbiol Infect Dis. 1987 Jul;7(3):199-204. doi: 10.1016/0732-8893(87)90005-8. Diagn Microbiol Infect Dis. 1987. PMID: 2820649
244 results
Jump to page
Feedback